Dr. St-Amand completed his doctoral studies at Laval University, and his postdoctoral studies at the University of British Columbia. In 1998, he optimized the SAGE method in his laboratory located in Japan, at the pharmaceutical company Otsuka. He is currently a full professor in the Department of Molecular Medicine at Laval University, and director of the Functional Genomics Laboratory and SAGE platform at the CHU Research Centre of Quebec. He is an expert in genetic engineering and functional genomics.
Dr. St-Amand’s research program aims to characterize the transcriptomes of several tissues and their regulation through physical exercise, a lipid-rich diet, and steroid hormones, in order to identify, clone and characterize functionally the genes of interest that can be used as therapeutic targets for coronary heart disease, obesity, and cancer. Dr. St-Amand’s laboratory is developing genetic engineering methods and bioinformatics programs, particularly for the analysis of functional genomics results. Dr. St-Amand developed the first SAGE platform in Canada. This powerful strategy makes it possible to compare all transcripts, including new genes, to identify the molecular mechanisms responsible for diseases.
Dr. St-Amand and his team are also studying in vitro cells and knockout mice to characterize the functions of candidate genes. These research projects will identify therapeutic targets to, in turn, develop therapeutic treatments for obesity and cardiovascular disease.
2705, boulevard Laurier
R-4720
Québec, Québec
Canada G1V 4G2
2705, boulevard Laurier
R-4775
Québec, Québec
Canada G1V 4G2
Latest news
Data not available
- Ghanemi, AbdelazizDoctoral studentCHUL+1 418-525-4444, extension 42296Abdelaziz.Ghanemi@crchudequebec.ulaval.ca
2705, boul. Laurier
R-4736
Québec, Québec
Canada G1V 4G2 - Yoshioka, MayumiEmployeeCHUL+1 418-525-4444, extension 46051+1 418-654-2298mayumi.yoshioka@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-4760-L2 et R-4775
Québec, Québec
Canada G1V 4G2
High-Fat Diet-Induced Trefoil Factor Family Member 2 (TFF2) to Counteract the Immune-Mediated Damage in Mice.
Journal ArticleAnimals (Basel), 11 (2), 2021, ISSN: 2076-2615.
Abstract | Links: 
Obesity as a Neuroendocrine Reprogramming.
Journal ArticleMedicina (Kaunas), 57 (1), 2021, ISSN: 1010-660X.
Abstract | Links:
Secreted Protein Acidic and Rich in Cysteine as A Regeneration Factor: Beyond the Tissue Repair.
Journal ArticleLife (Basel), 11 (1), 2021, ISSN: 2075-1729.
Abstract | Links:
Regeneration during Obesity: An Impaired Homeostasis.
Journal ArticleAnimals (Basel), 10 (12), 2020, ISSN: 2076-2615.
Abstract | Links:
Trefoil Factor Family Member 2 (TFF2) as an Inflammatory-Induced and Anti-Inflammatory Tissue Repair Factor.
Journal ArticleAnimals (Basel), 10 (9), 2020, ISSN: 2076-2615.
Abstract | Links:
Exercise and High-Fat Diet in Obesity: Functional Genomics Perspectives of Two Energy Homeostasis Pillars.
Journal ArticleGenes (Basel), 11 (8), 2020.
Abstract | Links:
Extracellular matrix/mitochondria pathway: A novel potential target for sarcopenia.
Journal ArticleMitochondrion, 50 , pp. 63-70, 2020, ISSN: 1567-7249.
Abstract | Links:
Secreted protein acidic and rich in cysteine and cancer: A homeostatic hormone?
Journal ArticleCytokine, 127 , pp. 154996, 2020, ISSN: 1043-4666.
| Links:
Secreted protein acidic and rich in cysteine and inflammation: Another homeostatic property?
Journal ArticleCytokine, 133 , pp. 155179, 2020, ISSN: 1043-4666.
| Links:
Secreted Protein Acidic and Rich in Cysteine: Metabolic and Homeostatic Properties beyond the Extracellular Matrix Structure
Journal ArticleAppl Sci (Basel), 10 , pp. 2388 (9 pages), 2020, ISSN: 2076-3417.
| Links:
Active projects
- Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
Recently finished projects
- Roles of exercise-induced gene, SPARC, against sarcopenia: Link between extracellular matrix and mitochondria., Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2014-04-01 to 2021-03-31